ReviewPublic health challenges2022
Revisiting the issue of access to medicines in Africa: Challenges and recommendations.
Review in Public health challenges, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
57 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Willingness to pay for National Health Insurance Services and Associated Factors in Africa and Asia: a systematic review and meta-analysis.Frontiers in public health · 2024Pooled it
- Systemic challenges in the supply and distribution of medicines in conflict-affected areas of Mali: a qualitative study.Global health action · 2026Article
- The Role of Research, Quality Improvement, and Training in Achieving Medicines Security in Nigeria: A Cross-Sectional Exploration of Stakeholders' Perspectives.Health science reports · 2026Article
- Pharmaceutical import landscape in Ethiopia: a cross-sectional study of importers' perspectives on business and regulatory challenges.Tropical medicine and health · 2026Article
- Availability of essential medicines in conflict-affected african regions: a systematic review and meta-analysis.Conflict and health · 2026Review
- Pharmaceutical Wastage in Public Health Facilities of Ethiopia: Determinants, Consequences, and Solutions.Public health challenges · 2026Article
- Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.Clinical pharmacology and therapeutics · 2026Review
- Article
- Essential medicines out of reach: a cross-sectional study of community-level access in Eastern Uganda.BMC health services research · 2026Article
- Drug stockouts and treatment delays in African health systems: impact on malaria morbidity and mortality.Annals of medicine and surgery (2012) · 2026Review
- An analysis of the registration of essential medicines in Namibia: a proxy measure of the availability of essential medicines.Journal of pharmaceutical policy and practice · 2026Article
- Adoption of international good manufacturing practices in the Nigerian pharmaceutical industry: promising results from a decade of investment.Journal of pharmaceutical policy and practice · 2026Review
- Article
- Prices, availability, and affordability of selected medicines for asthma management in Nigeria: a nationwide study.BMC health services research · 2025Article
- Mortality burden of bacterial antimicrobial resistance in East Africa: pooled analysis of modelled estimates.Tropical medicine and health · 2025Article
- HIV infection and immunosenescence: challenges and intervention strategies.BMC medicine · 2025Review
- An Equity-Focused Systematic Analysis of Antimicrobial Resistance National Action Plans in 14 West African Countries.Tropical medicine & international health : TM & IH · 2025Article
- Leveraging a people-centred approach to combat antimicrobial resistance in Africa.Tropical medicine and health · 2025Review
- Factors contributing to human and veterinary medicine shortages in developing countries: perspectives of suppliers and regulators in Namibia.Tropical medicine and health · 2025Article
- Disposal practices of unused and expired medications among healthcare practitioners in Ibadan, Nigeria: results from a cross-sectional survey.BMC health services research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Access to safe, effective, affordable, and quality medicines is an essential component of the right to health and is also one of the targets in the global development agenda. In this review article, we extensively discuss the challenges and issues surrounding access to medicines in the African region as well as provides recommendations for ensuring medicines security on the continent. Methods: We conducted narrative review with the use of data reported in published literature, reports, and grey literature available in African countries on topics pertaining access to medicines. The authors also snowballed further data to gather information for this review and narrative synthesis was conducted. Results: Africa faces a double burden of infectious and non-communicable diseases and the need for effective universal access to medicines cannot be deemphasized. However, access to medicines on the continent is not without issues and challenges. Some of which are the high burden of infectious diseases and non-infectious diseases, limited pharmaceutical industries and high costs of raw materials, overdependence on countries abroad for medicines, poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health financing mechanisms, lack of infrastructures and technical know-how, low investment on research and development, and circulation of fake and counterfeit medicines among others. Conclusion: This review reifies that access to medicines in Africa faces numerous challenges and it emphasizes the urgent need to address these issues as the continent geared towards strengthening its health systems for universal health coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.